IP-10, a -C-X-C- Chemokine, Elicits a Potent Thymus-dependent Antitumor Response in Vivo

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1993 Sep 1

PMID 8350046

Citations 109

Authors

A D Luster

P Leder

Affiliations

Soon will be listed here.

Abstract

IP-10 is a member of the -C-X-C-chemokine superfamily of proinflammatory cytokines whose secretion is induced by interferon gamma (IFN-gamma) and lipopolysaccharide (LPS). To date no function has been described for IP-10. We have genetically engineered tumor cells to secrete high levels of murine IP-10 and demonstrate that while IP-10 has no effect on the growth of these tumor cells in culture, it elicits a powerful host-mediated antitumor effect in vivo. The IP-10 antitumor response is T lymphocyte dependent, non-cell autonomous, and appears to be mediated by the recruitment of an inflammatory infiltrate composed of lymphocytes, neutrophils, and monocytes. These results document an important biologic property of IP-10 and raise the possibility that some of the T cell-directed effects of IFN-gamma and LPS may be mediated by this chemokine.

Citing Articles

The Laws of Attraction: Chemokines as Critical Mediators in Cancer Progression and Immunotherapy Response in Bladder Cancer.

Hassouneh Z, Kim M, Bowman N, Rao M, Zhang N, Huang G Cancers (Basel). 2024; 16(19).

PMID: 39409924 PMC: 11648100. DOI: 10.3390/cancers16193303.

Non-alcoholic fatty liver disease and heart failure: A comprehensive bioinformatics and Mendelian randomization analysis.

Zhang Y, Feng L, Guan X, Zhu Z, He Y, Li X ESC Heart Fail. 2024; 11(6):4185-4200.

PMID: 39143741 PMC: 11631243. DOI: 10.1002/ehf2.15019.

Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity.

Santosh Nirmala S, Kayani K, Gliwinski M, Hu Y, Iwaszkiewicz-Grzes D, Piotrowska-Mieczkowska M Front Immunol. 2024; 14:1321228.

PMID: 38283365 PMC: 10811018. DOI: 10.3389/fimmu.2023.1321228.

Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy.

Chen J, Amoozgar Z, Liu X, Aoki S, Liu Z, Shin S Cancer Immunol Res. 2024; 12(4):400-412.

PMID: 38260999 PMC: 10985468. DOI: 10.1158/2326-6066.CIR-23-0486.

Causal relationships between circulating inflammatory cytokines and diffuse large B cell lymphoma: a bidirectional Mendelian randomization study.

Yu J, Fu L, Zhang Z, Ding L, Hong L, Gao F Clin Exp Med. 2023; 23(8):4585-4595.

PMID: 37910257 DOI: 10.1007/s10238-023-01221-y.

References

Oi V, Morrison S, Herzenberg L, Berg P . Immunoglobulin gene expression in transformed lymphoid cells. Proc Natl Acad Sci U S A. 1983; 80(3):825-9. PMC: 393473. DOI: 10.1073/pnas.80.3.825. View

Chirgwin J, Przybyla A, MacDonald R, Rutter W . Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979; 18(24):5294-9. DOI: 10.1021/bi00591a005. View

Cepko C, Roberts B, Mulligan R . Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell. 1984; 37(3):1053-62. DOI: 10.1016/0092-8674(84)90440-9. View

Potter H, Weir L, Leder P . Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci U S A. 1984; 81(22):7161-5. PMC: 392097. DOI: 10.1073/pnas.81.22.7161. View

Luster A, Unkeless J, Ravetch J . Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature. 1985; 315(6021):672-6. DOI: 10.1038/315672a0. View

DANNER D, Leder P . Role of an RNA cleavage/poly(A) addition site in the production of membrane-bound and secreted IgM mRNA. Proc Natl Acad Sci U S A. 1985; 82(24):8658-62. PMC: 391495. DOI: 10.1073/pnas.82.24.8658. View

Murphy W, Sarid J, TAUB R, Vasicek T, Battey J, Lenoir G . A translocated human c-myc oncogene is altered in a conserved coding sequence. Proc Natl Acad Sci U S A. 1986; 83(9):2939-43. PMC: 323422. DOI: 10.1073/pnas.83.9.2939. View

Leder A, Pattengale P, Kuo A, Stewart T, Leder P . Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell. 1986; 45(4):485-95. DOI: 10.1016/0092-8674(86)90280-1. View

Seed B, Aruffo A . Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci U S A. 1987; 84(10):3365-9. PMC: 304871. DOI: 10.1073/pnas.84.10.3365. View

10.

Oliff A, Boyer M, Martinez D, Kiefer D, Vuocolo G, Wolfe A . Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 1987; 50(4):555-63. DOI: 10.1016/0092-8674(87)90028-6. View

11.

Luster A, Ravetch J . Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med. 1987; 166(4):1084-97. PMC: 2188708. DOI: 10.1084/jem.166.4.1084. View

12.

Kaplan G, Luster A, Hancock G, COHN Z . The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin. J Exp Med. 1987; 166(4):1098-108. PMC: 2188712. DOI: 10.1084/jem.166.4.1098. View

13.

Schagger H, von Jagow G . Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 1987; 166(2):368-79. DOI: 10.1016/0003-2697(87)90587-2. View

14.

Gottlieb A, Luster A, Posnett D, Carter D . Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J Exp Med. 1988; 168(3):941-8. PMC: 2189020. DOI: 10.1084/jem.168.3.941. View

15.

Matsushima K, Larsen C, DuBois G, Oppenheim J . Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med. 1989; 169(4):1485-90. PMC: 2189236. DOI: 10.1084/jem.169.4.1485. View

16.

Larsen C, Anderson A, Appella E, Oppenheim J, Matsushima K . The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science. 1989; 243(4897):1464-6. DOI: 10.1126/science.2648569. View

17.

Tepper R, Pattengale P, Leder P . Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell. 1989; 57(3):503-12. DOI: 10.1016/0092-8674(89)90925-2. View

18.

Walz A, DEWALD B, Von Tscharner V, Baggiolini M . Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J Exp Med. 1989; 170(5):1745-50. PMC: 2189513. DOI: 10.1084/jem.170.5.1745. View

19.

Watanabe Y, Kuribayashi K, Miyatake S, Nishihara K, Nakayama E, Taniyama T . Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci U S A. 1989; 86(23):9456-60. PMC: 298515. DOI: 10.1073/pnas.86.23.9456. View

20.

Sharpe R, Byers H, Scott C, Bauer S, Maione T . Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst. 1990; 82(10):848-53. DOI: 10.1093/jnci/82.10.848. View